FINGOLIMOD Spirig HC caps 0.5 mg 98 pce
7680676160043
CH-67616
L04AE01
01.99.0.
Reimbursement limitations:
GILENYA3
Traitement de la sclérose en plaques (SEP) récurrente-rémittente chez l’adulte. Première prescription par un neurologue.
1 / 3
google
Details
- Product number
- 6761601
- CPT
- -
- Packaging group
- 98
- Unit
- Kapsel(n)
- Composition
- fingolimodum 0.5 mg ut fingolimodi hydrochloridum, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum) pro capsula.
Articles (1)
Fingolimod Spirig HC 0,5 mg, Kapseln
Kapseln
98
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 1464.85
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2025
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 67616
- Drug name
- Fingolimod Spirig HC, Kapseln
- Galenic form
- KAHA
- ATC Code
- L04AE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/06/2021
- Authorization expiration date
- 24/06/2026
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FINGOLIMOD Spirig HC caps 0.5 mg 98 pce
- Description (DE)
- FINGOLIMOD Spirig HC Kaps 0.5 mg 98 Stk
- Market launch
- 25/06/2021
- Narcotic (BTM)
- No